Ovid Therapeutics Inc. (OVID) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -13.9M | -10.41M | -12.87M | -4.77M | -10.28M | -10.01M | -15.01M | -14.26M | -16.69M | -11.91M | -10.05M | -11.71M | -12.11M | -9.18M | -12.68M | -13.29M | -20.09M | -12M | -10.87M | -19.42M |
| Operating CF Margin % | - | -1449.58% | -9751.52% | -76.12% | -7907.69% | -13168.42% | -8674.57% | -8434.91% | -11274.32% | -8388.95% | -9221.1% | -15607.14% | -18351.91% | -19826.56% | -114180.99% | - | -1389.71% | - | - | - |
| Operating CF Growth % | -35.2% | -4% | 14.23% | 66.51% | 38.39% | 15.99% | -49.31% | -21.78% | -37.76% | -29.82% | 20.71% | 11.91% | 39.7% | 23.53% | -16.6% | 31.56% | -112.48% | 17.31% | -639.88% | -12.93% |
| Net Income | -16.99M | 9.66M | -12.16M | -4.68M | -10.23M | -9.25M | -14.01M | 8.52M | -11.69M | -15.32M | -11.25M | -12.41M | -13.36M | -11.5M | -11.97M | -14.59M | -16.11M | -25.15M | -11.38M | -15.79M |
| Depreciation & Amortization | 35K | 17K | 17K | 99K | 141K | 147K | 169K | 148K | 136K | 401.39K | 402.46K | 394.77K | 397.96K | 439.95K | 415.36K | 452.48K | 73.81K | 56.87K | 52.18K | 53.22K |
| Stock-Based Compensation | 0 | 1.2M | 0 | 1.22M | 1.28M | 0 | 1.31M | 0 | 1.97M | 1.79M | 1.63M | 0 | 0 | 1.73M | 0 | 1.72M | 1.32M | 0 | 1.16M | 1.26M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -105.41K | 346.35K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 722K | -21.42M | 960K | -164K | -167K | -49K | -733K | -27.11M | -5.36M | -2.33M | -1.21M | 1.34M | 1.12M | 225.64K | 1.24M | 612.17K | -1.06M | 7.77M | 0 | 0 |
| Working Capital Changes | 2.33M | 134K | -1.69M | -1.24M | -1.3M | -853K | -1.75M | 4.19M | -1.74M | 3.65M | 28.98K | -1.03M | -270K | -66.15K | -2.37M | -1.49M | -4.31M | 5.33M | -701.86K | -4.94M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.02M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 3.62M | 246K | -2.24M | 2M | -1.24M | 481K | -2.01M | 1.12M | -107K | 2.49M | -2.55M | 1.93M | -121.42K | 919.84K | -3.58M | 2.36M | -4.87M | 3.99M | 2.23M | -2.24M |
| Cash from Investing | 5.95M | -72.06M | 5.05M | 12.05M | 5.1M | 21.29M | 292K | 12.82M | 20.19M | -48.52M | -4.36M | 20.07M | 30.23M | -4.17M | -1.96M | -80.68M | -1.08M | -161.96K | -64.03K | -1.58M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 4K | 4K | -34K | -19K | -1.22K | -5.25K | -117.43K | -13.56K | -119.94K | -18.6K | -1.04M | -76.17K | -161.96K | -22.05K | 11.51K |
| CapEx % of Revenue | - | - | - | - | - | 5.26% | 2.31% | 20.12% | 12.84% | 0.86% | 4.81% | 156.58% | 20.55% | 259.16% | 167.54% | - | 5.27% | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48.5M | 4.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -48.1K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 1K | 0 | -116K | 0 | -48.5M | -4.35M | 0 | 0 | 56.94K | 0 | -221.11K | -1M | 0 | 6.12K | -1.6M |
| Cash from Financing | 88.98M | 75.18M | 15K | 0 | 13K | 0 | 38K | 356K | 228K | 30.03M | 223.72K | 211.1K | 66.99K | -43.6K | 81.63K | 109.55K | 33.08K | 109.18K | 549.05K | 116.19K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 88.98M | 75.18M | 15K | 0 | 13K | 0 | 38K | 356K | 228K | 33.39K | 223.72K | 211.1K | 66.99K | 0 | 81.63K | 0 | 33.08K | 130.49K | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -43.6K | 0 | 109.55K | 0 | -21.31K | 549.05K | 116.19K |
| Net Change in Cash | 80.91M | -7.46M | -7.8M | 7.28M | -5.17M | 11.28M | -14.68M | -1.08M | 3.73M | -30.4M | -14.19M | 8.57M | 18.18M | -13.39M | -14.55M | -93.86M | -21.13M | -13.98M | -10.39M | -20.88M |
| Free Cash Flow | -13.9M | -10.41M | -12.87M | -4.77M | -10.28M | -10.03M | -15M | -14.29M | -16.7M | -11.91M | -10.06M | -11.71M | -12.13M | -9.24M | -12.69M | -14.55M | -20.13M | -12.16M | -10.89M | -19.42M |
| FCF Margin % | - | -1449.58% | -9751.52% | -76.12% | -7907.69% | -13197.37% | -8672.25% | -8455.03% | -11287.16% | -8389.81% | -9225.91% | -15617.53% | -18372.45% | -19962.68% | -114348.5% | - | -1392.89% | - | - | - |
| FCF Growth % | -35.2% | -3.77% | 14.2% | 66.59% | 38.46% | 15.81% | -49.19% | -21.99% | -37.76% | -28.95% | 20.79% | 19.5% | 39.77% | 24.03% | -16.6% | 25.07% | -112.51% | 16.71% | -620.71% | -12.57% |
| FCF per Share | -0.19 | -0.13 | -0.18 | -0.07 | -0.14 | -0.14 | -0.21 | -0.20 | -0.24 | -0.17 | -0.14 | -0.17 | -0.17 | -0.13 | -0.18 | -0.21 | -0.29 | -0.18 | -0.16 | -0.29 |
| FCF Conversion (FCF/Net Income) | 0.82x | -1.08x | 1.06x | 1.02x | 1.00x | 1.08x | 1.07x | -1.67x | 1.43x | 0.78x | 0.89x | 0.94x | 0.91x | 0.80x | 1.06x | 0.91x | 1.25x | 0.48x | 0.96x | 1.23x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |